This document is the first annual report to donors on PATH's use of flexible funding (the "Catalyst Fund") and includes highlights of our work to pursue state-of-the-art diagnostic tools for low-resource settings, strengthen avian influenza prevention in countries at high risk of epidemics, and move forward with a fortified rice premix that is being adopted in several countries in Asia.